Bioinformatics In Pharmaceutical Industry
Exploratory study on bioinformatics within the pharmaceutical industry
i am writing on behalf of a consulting firm that conducts expert interviews in support of industry-wide studies for many of the world's fortune 1000 companies. We are an authorized zintro partner.
for a current study, we are seeking expertise to help us understand the use and application of bioinformatics at large pharmaceutical companies. We are interested in all stages of r&d and drug development, specifically with regard to proteomics.
We are particularly interest in experts with recent or current experience at sanofi, eli lilly, astrazenecaglaxosmithkline. Novartis, pfizer, abbvie, ferring, pharmaceuticals, ironwood pharmaceuticals, protagonish therapeutics, ipsen, intrexon, biogen, shire.
Please note that we are only interested in your personal point of view and expert insight and are not seeking any confidential information.
we are scheduling 45-60 minute phone discussions with experts this and next week and are happy to offer a negotiable usd 250 compensation for each interview.
please note that we are handling the standard zintro fee separately, hence the expert is not involved in paying this. If you kindly let me know your contact details (email and phone/skype), i could provide more specifics on the study and standard process.
we would welcome any referrals to other relevant experts as well.
shannon+23 Other Responses
We are hosting webinars presented by zintro experts as a way to source new clients for you. We promote the webinar invitation to our 180,000 users through email and other channels, then we post the webinar to our blog and promote the video. You can view some examples here.
This initiative would be completely free for you. You would be able to include your zintro profile in the webinar to promote your services and you would only pay us 15% of any engagement generated through the webinar effort.
Presentations are normally 40 minutes and focus on subjects that might showcase your expertise and help you source new clients. After your presentation, we will leave an additional 15 minutes of time to answer attendee questions live.
To view some examples of past webinars, go to: https://blog.Zintro.Com/webinars/
i'm coordinating the schedule for the next available webinar slots and would like to know if you are available for any of the following dates:
july 16th, 2015 1:00 pm edt
july 30th, 2015 1:00 pm edt
august 13th, 2015 2015 1:00 pm edt
august 27th, 2015 2015 1:00 pm edt
september 10th, 2015 2015 1:00 pm edt
september 24th, 2015 1:00 pm edt
october 8th, 2015 1:00 pm edt
october 22nd, 2015 1:00 pm edt
november 5th, 2015 1:00 pm edt
november 19th, 2015 1:00 pm edt
december 3rd, 2015 1:00 pm edt
we usually hold a practice session on the monday preceding the presentation date. We can do the practice session at whatever time is most convenient for you.
In addition to your preferred dates, i would appreciate if you could provide the following information:
1) zintro id or sign up email address
2) complete name and title
3) company you work for
4) topic of your presentation+27 Other Responses
Business Development In Biotechnology
We are looking for a business expert to help with business development and negotiation in a fast growing biotechnology company in northern california.
experience in biotechnological company and global sustainability, extensive global experience for growth and deployment.Experience in applying innovation and creativity to business development, negotiation and building alliances within the biotechnology, pharmaceutical
areas of expertise:
seeking experts with knowledge of business development in biotech; biotechnology and catapult the company into the next growth phase
note: since we look for a long tern relationship with qualified business expert, the phone interview would be required. Thanks.+39 Other Responses
Biotechnology Raw Material Inventory Management
We are doing a research on raw material inventory management in biotechnology industry focused to companies in space of gene therapy, ultra rare disease, small/large molecule. The raw material includes : media/biologics, bioprocessing, misc, chemicals, filters, resin, single use and others.
I need information on the following points:
- best practices in biotech to reduce expiration write-offs of the raw materials, what is the benchmark for raw materials write-offs in the industry - best in class, average, laggards, respective case studies
- best practices adopted by biotech companies to manage inventory
-points of leverage to use when negotiating with suppliers aside from volume and payment terms
+undefined Other Responses
Biomedical Start Ups Pr
I recently graduated from rose-hulman institute of technology (rhit) with a double major in biomedical engineering and biochemistry molecular biology. I am currently a graduate student at rhit pursuing a master of science in engineering management and working on my integrated project. This project focuses on bringing a new type of knee implant to market. I am interested gathering advice from qualified consultants that can help me develop a realistic perspective on developing a start-up and sustainable competitive advantage for a company based on this novel product. Any advice pertaining to the formation of a business plan and what due diligence should be done will be helpful. At the moment, i am researching areas such as the regulatory approval process, intellectual property, preliminary financial analysis, market analysis, and analysis of competitors. Any advice and guidance is greatly appreciated.+15 Other Responses
As i said we have a biotechnology factory which is designed for a product named bioflash to fight against malaria pesticide.
We have approval of who and fao. We need an expert who can help us for other profitable bio-products which our factory has potential.+27 Other Responses
Pharmaceutical Market Access
Director, market access opportunity onsite in california, usa.
the director market access will be a strategic business leader responsible for developing a comprehensive reimbursement, pricing, contracting, and distribution strategy for heplisav-b in the us to support launch in 2016. In addition, the director market access will provide guidance and insights to support commercial planning for pipeline products.
build out the infrastructure for the pricing, contracting, distribution and payer team.
Develop and execute market access strategies focused on reimbursement, pricing, contracting, and commercial distribution related to heplisav-b and future pipeline products across multiple disease states.
Apply deep understanding of national and local reimbursement trends and policies, payer coding and billing, and newly forming health care delivery models to develop managed market strategies.
Lead development and execution of contracting strategy for heplisav-b and future pipeline products.
Lead all aspects of payer coverage to support appropriate reimbursement of heplisav-b.
Develop dossier and other materials as needed to support payer acceptance.
Responsible for all distributor and gpo accounts, including contract negotiations, ongoing relationship management, and day to day operational activities.
Execute retail pharmacy channel distribution strategy in conjunction with product marketing.
Manage 3pl activities related to interactions with distribution network.
Work with commercial analytics to develop metrics/dashboards to assess performance of pricing and contracting strategy.
at least 10 years of experience in the biotech or pharmaceutical industry;
at least 5 years’ experience in a market access/reimbursement/key account position with proven success
ba/bs with relevant experience;
understanding of billing and coding with experience in the implementation of pricing and contracting strategy;
comprehensive knowledge of us healthcare reimbursement system in both commercial and government payer;
demonstrated experience with specialty pharmacy and wholesalers.+6 Other Responses
Biotech Manufacturing Procedure
We need an expert witness in the field of biotech manufacturing procedures and or pharmaceutical manufacturing best practice. To advise court on issues relating to quality assurance and the failure to follow procedure (or not, as the case may be)+20 Other Responses
Life Science Procurement Maturity
We are a global research and advisory firm and are seeking experts who can assist us with insights (both qualitative and quantitative) on the maturity of procurement as a function across countries / regions.
This entails providing us with comparative data / benchmarks that help indicate the maturity of countries in terms of their procurement practices. The applicable industry is life sciences.
The list of regions and countries include:
in western europe: germany, france, uk, holland, spain, italy, switzerland, belgium, (norway & finland nice to have but not mandatory)
in apac: india, china, singapore (australia nice to have but not mandatory)
in latam: brazil, argentina, colombia, mexico
we would like to engage via phone consult with experts knowledgeable on the aforementioned topic.
We are looking for a phone consult for a time period of 1-2 hours to discuss the same. Please supplement your expression of interest with an indication of the approach that you are likely to adopt to answer the aforementioned question.
budha+13 Other Responses
I am looking for somebody/consultor with specific knowledge in the pharma and biotech sector. The topic is launching a product for the reproductive female health. I expect that this person can contribute and support launching products, giving support to the marketing/sales department, pricing and competititors anlaysis. It is prefered experience in different countries emea and fluency in at least three european languages.
Statistic analysis as well scientifical writing are desired.+10 Other Responses
I am looking for a biomedical engineer/scientist with experience in developing medical technologies especially using nanotechnology. I need advice on various aspects of starting up a medtech/biotech company including financing, product development, technology transfer, business and strategic planning, and navigating the regulatory path.+25 Other Responses
Drugs With Current/expired Patents
Looking for c-level responses from manufacturers of drugs with current and/or expired patents to take to china via established distribution network that handles sfda, regulatory/government relationships as well national, regional and local distribution channels.+12 Other Responses